Application of machine learning to develop and validate a pain risk prediction model for patients with non-small cell lung cancer after video-assisted thoracoscopic surgery: A single-center retrospective study

应用机器学习技术开发和验证非小细胞肺癌患者胸腔镜辅助手术后疼痛风险预测模型:一项单中心回顾性研究

阅读:2

Abstract

This study aimed to develop a machine learning (ML)-based model to identify risk factors for postoperative pain following video-assisted thoracoscopic surgery (VATS) lobectomy in non-small cell lung cancer (NSCLC) patients. This retrospective study analyzed data from 100 NSCLC patients who underwent VATS. Least absolute shrinkage and selection operator (LASSO) regression with 10-fold cross-validation identified predictive factors. Patients were split into training (80%) and testing (20%) sets. Seven ML algorithms were trained, with performance evaluated via receiver operating characteristic curve, sensitivity, specificity, and accuracy. The shapley additive explanations (SHAP) method interpreted the best-performing model. LASSO regression identified 11 predictors. The random forest (RF) model achieved the highest predictive performance (AUC: 0.901, 95% CI: 0.833-0.969). SHAP analysis highlighted elevated pro-gastrin releasing peptide, tumor volume, red cell distribution width, lactic dehydrogenase, and white blood cell count as risk factors, while dexmedetomidine and higher hemoglobin were protective. A simplified model retained comparable accuracy (DeLong test P = .4846). The RF-based ML model effectively predicts post-VATS pain risk in NSCLC patients, demonstrating potential to guide future research on preoperative risk assessment and personalized interventions. External validation in a larger cohort is required before clinical application.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。